J 2024

Adjuvant radiotherapy after brain metastasectomy: analysis of consecutive cohort of 118 patients from real world practice

FADRUS, Pavel; Václav VYBÍHAL; Ivana ROŠKOVÁ; Iveta SELINGEROVÁ; Martin SMRČKA et. al.

Basic information

Original name

Adjuvant radiotherapy after brain metastasectomy: analysis of consecutive cohort of 118 patients from real world practice

Authors

FADRUS, Pavel; Václav VYBÍHAL; Ivana ROŠKOVÁ; Iveta SELINGEROVÁ; Martin SMRČKA; Radim JANČÁLEK; Jiří ŠÁNA; Ondřej SLABÝ; Petr POSPÍŠIL; Ludmila HYNKOVÁ; Jan GARCIC; Renata BELANOVÁ; Jan KRISTEK; Andrea ŠPRLÁKOVÁ-PUKOVÁ; Zdeněk MACKERLE; Vilém JURÁŇ; Marek SOVA; Eduard NEUMAN; Hana VALEKOVÁ; Radek LAKOMÝ; Miloš HOLÁNEK; Roman HRSTKA; Michaela ŠVAJDOVÁ; Kateřina POLÁCHOVÁ; Ivana KOLOUŠKOVÁ; Pavel ŠLAMPA and Tomáš KAZDA

Edition

Reports of Practical Oncology and Radiotherapy, GDANSK, VIA MEDICA, 2024, 1507-1367

Other information

Language

English

Type of outcome

Article in a journal

Country of publisher

Poland

Confidentiality degree

is not subject to a state or trade secret

References:

RIV identification code

RIV/00216224:14110/24:00136239

Organization

Lékařská fakulta – Repository – Repository

UT WoS

001293214500001

EID Scopus

2-s2.0-85188780134

Keywords in English

brain metastases; surgery; radiotherapy; tumor cavity; overall survival

Links

LX22NPO5102, research and development project. NU22-03-00159, research and development project. NV18-03-00469, research and development project. BBMRI.cz IV, large research infrastructures. CZECRIN IV, large research infrastructures.
Changed: 10/6/2025 00:50, RNDr. Daniel Jakubík

Abstract

In the original language

lt; 0.001; hazard ratio (HR) 0.47, p = 0.004] with median follow-up of 58 months. Cumulative incidence for local, distant, and extracranial control was not significantly different between groups, with 12-month cumulative control of 22% vs. 18%, 44% vs. 29%, and 35% vs. 32% for stereotactic and WBRT group, respectively. WBRT was an independent factor for better distal brain control. Conclusions: Real world data demonstrating significantly better overall survival in patients treated with postoperative targeted radiotherapy compared with postoperative WBRT is presented, with no significant difference in cumulative incidence for local or distant brain control. The majority of patients with targeted radiotherapy had a fractionated dose schedule with outcomes comparable to single-dose radiation trials of postoperative targeted radiotherapy.

Files attached